Chaperone-usher pathway pili are extracellular proteinaceous fibres ubiquitously found on Gram-negative bacteria, and mediate host-pathogen interactions and biofilm formation critical in pathogenesis in numerous human diseases 1 . During pilus assembly, an outer membrane macromolecular machine called the usher catalyses pilus biogenesis from the individual subunits that are delivered as chaperone-subunit complexes in the periplasm. The usher orchestrates pilus assembly using all five functional domains: a 24-stranded transmembrane β -barrel translocation domain, a β -sandwich plug domain, an amino-terminal periplasmic domain and two carboxy-terminal periplasmic domains (CTD1 and CTD2) 2-6 . Despite extensive structural and functional characterization, the mechanism by which the usher is activated to initiate pilus biogenesis is unknown. Here, we present the crystal structure of the full-length PapC usher from Escherichia coli in complex with its cognate PapDG chaperone-subunit complex in a pre-activation state, elucidating molecular details of how the usher is specifically engaged by allosteric interactions with its substrate preceding activation and how the usher facilitates the transfer of subunits from the amino-terminal periplasmic domain to the CTDs during pilus assembly. This work elucidates the intricate workings of a molecular machine that catalyses chaperone-usher pathway pilus assembly and opens the door for the development of potent inhibitors to block pilus biogenesis.
process termed donor-strand complementation, the chaperone-a boomerang shaped protein comprising two complete immunoglobulin-like domains-provides in trans its G1 β -strand to complete the pilin's immunoglobulin-like fold in a non-canonical fashion 17, 18 . Chaperone-pilin complexes are then guided to the outer membrane usher-a β -barrel channel that catalyses subunit-subunit interactions through a reaction called donor-strand exchange (DSE), wherein an amino (N)-terminal extension on every subunit completes the canonical immunoglobulin fold of its neighbouring subunit in a zip-in zip-out mechanism that drives the dissociation of the chaperone [19] [20] [21] .
DSE events are coordinated by the PapC usher and require all five functional domains of the usher for productive interactions between pilus subunits during fibre polymerization 4, 22 . In biolayer interferometry (BLI) studies, the isolated N-terminal periplasmic domain (NTD) binds the chaperone-adhesin PapDG complex with the highest affinity relative to other chaperone-subunit complexes 23 . Thus, P pilus assembly is thought to begin with the recruitment of PapDG to the NTD of apo-PapC. Unlike the NTD, the plug domain and plug domain-NTD (PD-NTD) complex bind the chaperone and all chaperone-subunit complexes with nearly equal affinity 23 . Based on studies in the type 1 pilus system, chaperone-subunit complexes are transferred from the NTD to the C-terminal periplasmic domain (CTD) by an unknown mechanism 4, 22 . The PapC CTD2 has been shown to promote the dissociation of PapDG from the NTD in vitro 23 . In BLI studies, CTD2 binds to all tested chaperone-subunit complexes except the PapDH complex 23 . Incorporation of PapH results in termination of pilus biogenesis 24, 25 . Thus, the CTDs are thought to facilitate the hand-off of chaperone-subunit complexes from the NTD to the CTDs by an unknown mechanism, resulting in their association at the usher CTDs during activation of the usher for the initiation of pilus assembly and all subsequent pilus assembly elongation steps 4, 22 . We define usher activation as a complex multistep mechanism, which begins with the interactions between the chaperone-adhesin and usher NTD and results in: (1) its association with NTD in the periplasm; (2) transfer of chaperone-adhesin from the NTD to CTDs; and (3) plug domain displacement. Here, we present an X-ray crystal structure of the ternary PapC-PapDG complex in the process of transitioning from an inactive to a postactivation state (termed here a pre-activation state), delineating detailed molecular interactions between PapDG and the NTD and Letters NaTurE MICrobIoloGy CTD2 of PapC. Addition of the PapDF chaperone-pilin complex to the pre-activated PapC-PapDG complex results in DSE between PapG and PapF. Mutations in the NTD-CTD2 interface significantly reduce pilus assembly in vivo and diminish the ability of PapC to promote PapG-PapF DSE in vitro. Together with functional characterization and comparison with the post-activation structures in the type 1 pilus system, our results reveal critical details about the molecular mechanism of usher activation and chaperone-adhesin translocation from the usher NTD to CTD.
The ushers that assemble the most well-characterized CUP pilithe type 1 pilus and P pilus-have a sequence identity and similarity of 31 and 43%, respectively, but exhibit high structural similarity and are thought to share common assembly mechanisms. Thus, genetic, biochemical and biophysical studies conducted in either pilus system are often combined to elucidate the molecular determinants of usher function during pilus biogenesis. However, variations in pilus assembly mechanisms have been noted in different pilus systems. In type 1 pilus biogenesis, the FimH adhesin is sufficient to activate the FimD usher to initiate pilus assembly 26, 27 . In marked contrast, in the P pilus system, efficient activation of the PapC usher involves a concerted mechanism requiring both the PapG adhesin and the subsequent pilus subunit and adaptor protein, PapF [28] [29] [30] . To elucidate the mechanism by which PapC is primed for activation and its transition to a post-activation state we: (1) reconstituted a ternary PapC-PapDG complex in vitro without PapF (Fig. 1a ,b); (2) crystallized the ternary PapC-PapDG complex; and (3) determined the crystal structure at 3.7 Å resolution ( Fig. 1d and Supplementary  Table 1 ). To demonstrate the activity of the isolated PapC-PapDG complex, we used a DSE assay to determine whether the usher in the PapC-PapDG complex could promote DSE between PapG and PapF on addition of the PapDF complex ( Fig. 1c ). Indeed, a sodium dodecyl sulfate (SDS) stable PapGF band appeared over time, albeit slowly, signifying that the purified PapC-PapDG ternary complex is capable of promoting DSE in vitro. In the time course tested, the DSE reaction between PapG and PapF does not achieve 100% completion, but this is consistent with the reported DSE rate between PapG and PapF (~50% completion in 120 h) 31, 32 . Moreover, the sample at the end of the time course could be purified and was shown to have formed a quaternary PapC-PapDFG complex ( Supplementary  Fig. 1 ). Although it is likely that the reconstituted PapC-PapDG complex exists as a mixture of pre-activated and post-activated conformations, the crystal structure reveals a pre-activated usher state transitioning to a post-activation state in which: (1) the plug domain still resides within the β -barrel lumen; and (2) the NTD and CTDs interact with each other and both are also engaged in binding PapDG (Figs. 1d and 2a,b). This is in sharp contrast with the previously determined crystal structures of the usher-chaperoneadhesin FimD-FimCH and usher-tip fibrillum FimD-FimCFGH complexes from the type 1 pilus system, in which the FimD usher has already transitioned to a post-activation state 4, 22 . In the FimD-FimCH and FimD-FimCFGH structures: (1) the plug domain of FimD has translocated into a periplasmic PD-NTD complex; (2) the chaperone-subunit complex has been transferred to the CTDs; and (3) the adhesin lectin domain (FimH L ) is inserted into the β -barrel pore ( Fig. 2a) . Notably, the FimD-FimCH structure was achieved by limited proteolysis with trypsin before crystallization 4 , which resulted in cleavage of the N-terminal tail of the FimD usher-a critical motif for binding the chaperone-adhesin complex and subsequent chaperone-subunit complexes 3, 33, 34 . Since the critical NTD tail was removed in that study, the NTD-chaperone-adhesin and NTD-CTD2 interactions elucidated in our wild-type PapC-PapDG structure, in which the N-terminal tail of the PapC usher is critically engaged with both the chaperone-adhesin and in the NTD-CTD2 interface, could not be observed. Thus, this also raises the possibility that all (full-length) ushers, when incubated with their cognate chaperone-adhesin complex, remain in a pre-activation state until an additional subunit is recruited to the usher, competing for the N-terminal tail residues to release the chaperone-adhesin from the NTD to undergo complete translocation to the CTDs and enter the translocation domain lumen ( Supplementary Fig. 2a ).
In the PapC-PapDG structure, both the NTD and CTD2 are in substantially different positions compared with the previous type 1 
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pilus post-activation structures ( Fig. 2c,d ). These large domain rearrangements are made possible by flexible linkers connecting the NTD to the translocation domain and CTD2 to CTD1. CTD1 remains stationary between the pre-activation and post-activation states, suggesting that CTD2 is the dynamic component of the bipartite CTD of the usher. The PapDG complex in our structure has an essentially identical structure to isolated PapDG ( Supplementary Fig. 3 ). The adhesin lectin domain (PapG L ) resides at the base of the β -barrel, burying ~490 Å 2 of surface area, and does not interact with any periplasmic domains of the usher (Fig. 2e ). The adhesin pilin domain (PapG P ) moves along the same rotational axis as CTD2 ( Fig. 2e ).
The initial binding of the PapC usher NTD and the PapDG chaperone-adhesin complex does not immediately elicit the plug domain displacement that primes the β -barrel for pilus extrusion through the pore. Conceptually, the plug domain displacement may occur concurrently with recruitment of the subsequent chaperone-subunit complex, PapDF, to the NTD and translocation of PapDG to the CTDs ( Supplementary Fig. 2a ). Alternatively, complete translocation of PapDG to the CTDs might elicit plug domain displacement followed by recruitment of PapDF to a PD-NTD complex ( Supplementary Fig. 2b ). While the plug domain resides within the pore lumen, the periplasmic domains make extensive contacts with PapDG, as well as with each other, giving rise to a pre-activated usher in the process of activation. The PapC NTD interacts, via the first 11 amino acids of its N-terminal tail, with PapD ( Fig. 3a) . In particular, the conserved F3 of PapC plugs into a hydrophobic pocket comprising residues P30, L32, I93 and P95 of PapD ( Fig. 3a ). Mutation of F3 of the usher or L32 and I93 of the chaperone abolishes pilus assembly, suggesting that this interface is critical in usher function 3, 34 . Additionally, the usher CTD2 also contacts PapD, with D762 of CTD2 forming a salt bridge with K44 of PapD-an interaction also observed in the FimD-FimCH and FimD-FimCFGH structures ( Fig. 3b) 4, 22 .
Remarkably, direct intra-usher interactions between the usher NTD and CTD2 are also observed at the NTD-PapDG-CTD2 interface ( Fig. 3c ). Despite the medium resolution of the structure, the N-terminal tail residues 12-21 of the NTD are well resolved in the electron density map ( Supplementary Fig. 4 ) and form extensive interactions with the bottom cleft of CTD2, particularly the β 1-β 2 and β 5-β 6 loops in CTD2 ( Fig. 3c ). While the interactions between CTD2 and the chaperone are observed in the post-activation FimD-FimCH structure ( Supplementary Fig. 5 ), the NTD-CTD2 interface is an unprecedented, unique feature in our pre-activation PapC-PapDG structure. This interface was not observed in the FimD-FimCH structure because the NTD motif was proteolytically removed by trypsin to aid in crystallization 6 . To evaluate the physiological relevance of this NTD-CTD2 interface, we made multiple mutations in amino acids comprising this interface, with a focus on an N-terminal α -helix in the usher NTD that is positioned directly next to CTD2 ( Fig. 3c) 3, 33 . To investigate their functional importance, we tested the ability of each PapC mutant to complement a Δ papC pap operon (papAHDJKEFG) in a haemagglutination assay, which is a measure of overall levels of piliation on the bacterial surface (haemagglutination assay titre analysis) ( Fig. 3d ). All mutations in this region-especially mutants destabilizing the α -helix-resulted in a significant reduction in the haemagglutination assay titre, ranging from complete ablation of the haemagglutination assay titre to a 2-to 16-fold decrease in the haemagglutination assay titre (Fig. 3d ). These defects in P pilus assembly are specific to this interface as mutations of surrounding residues on the N-terminal tail or CTD2 have no effect ( Supplementary Fig. 6 ).
To further interrogate the role of this interface in usher activation, we selected four PapC mutants (D17P, (16) (17) (18) (19) (20) A, F21A and F745A) and tested their ability to first form a stable ternary complex with PapDG and then promote DSE between PapG and PapF ( Fig. 4 ). Mutations destabilizing the N-terminal α -helix (D17P or (16) (17) (18) (19) (20) A) or a residue flanking the end of the α -helix (F21A) resulted in inability of the mutant PapC ushers to form a stable ternary complex in vitro ( Fig. 4a-c) . Interestingly, the F21A PapC mutant had previously been characterized as exhibiting a haemagglutination assay titre defect and reduced association with PapDG, and was proposed to be involved in subunit discrimination during pilus assembly 28 . In light of our structure, it appears that this residue may play a role in stabilizing an NTD-CTD2 interface during a pre-activation usher state. In contrast with the NTD mutants, the CTD2 mutant (F745A) retained its ability to form a stable ternary complex with PapDG in vitro but was not able to efficiently promote DSE between PapG and PapF relative to wild-type PapC-PapDG ( Fig. 4d-f ). Taken together, these results show that the NTD-CTD2 interaction is essential for stable association of PapDG with the PapC usher and translocation of subunits from the NTD to CTDs, further suggesting that our wild-type PapC-PapDG structure represents a productive on-pathway intermediate rather than an off-pathway conformation owing to detergent solubilization and crystallization, although additional studies will be required to address this possibility. Moreover, our structure-function analysis of PapC-PapDG suggests that CTD2 drives subunit transfer, potentially by using the avidity of its interactions with both the NTD and PapD to competitively displace subunits from the NTD during pilus biogenesis (Fig. 3e ). Several lines of evidence further support this competitive displacement mechanism. First, previous BLI studies have shown that in isolation CTD2 can promote dissociation of a chaperone-adhesin bound to the NTD 23 . Second, it has been shown in the type 1 pilus system that upon usher activation the CTDs are the high-affinity binding site (K d = 40 nM) in the full-length usher compared with the NTD (K d = 389 nM) 35 . Therefore, these data suggest that this differential affinity potentially drives translocation from the NTD to the CTDs, and our structure further shows that allosteric destabilization of the chaperone subunits at the NTD may be facilitated by a direct interaction between the NTD and CTD2. The CUP represents an ideal system for studying the mechanisms by which binding and allosteric interactions drive sequential steps in a multi-domain assembly machine without ATP or other energy inputs. This work provides insight into the mechanism by which the outer membrane usher transfers substrates from its N terminus to its C terminus via an unexpected interaction between two periplasmic domains. Previously, bicyclic 2-pyridone compounds termed pilicides were determined to be inhibitors of pilus biogenesis by specifically blocking chaperone-subunit interactions with the N-terminal tail of the usher NTD 36 . In light of our structure, structure-activity relationship analysis could be used to design even more potent inhibitors that bind to this critical chaperone-usher interface. Furthermore, our structure potentially provides a template for the design of novel small molecules that sterically block the NTD-CTD2 interface to selectively hinder the usher from acting as an assembly platform for the development of antibiotic-sparing therapeutics. In summary, the PapC-PapDG structure and analysis of its activity in vitro provides an extraordinary view of a bacterial nanomachine caught in the act of being primed to catalyse Replicates are biological. e, Proposed mechanism of subunit transfer from NTD to CTD2. Superimposition of PapC-PapDG with FimD NTD-FimC-FimH P (PDB ID: 1ZE3) shows that CTD2 would directly clash with the NTD as it interacts with chaperone-adhesin during the initial targeting step. Subunit transfer may occur when CTD2 reaches over to interact with the N-terminal tail and chaperone (1) , which results in displacement of the NTD from the main interaction interface (2).
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macromolecular protein assembly across the outer membrane. Moreover, this structure may facilitate the development of new drugs that block chaperone-adhesin translocation to prevent assembly of one of the bacterium's major virulence factors.
Methods
Expression and purification of the full-length wild-type PapC usher. Plasmid pDG2 encoding wild-type PapC, with a thrombin cleavage site and a 6× His tag added to the C terminus, and the multi-porin mutant BL21(DE3)Omp8 E. coli strain were used for PapC expression, as previously described 37 . For protein expression, E. coli was grown at 37 °C with aeration in Luria-Bertani liquid medium supplemented with 100 µ g ml −1 ampicillin and was induced at an OD 600 of 0.6-0.8 for 2 h at 37 °C by the addition of 0.1% l-arabinose. To isolate the outer membrane fraction, resuspended cells supplemented with 1× EDTA-free Protease Inhibitor Cocktail (Pierce) and DNAse I were subjected to microfluidizer cell disruption via 4 passes at 30 kPsi. Unbroken cells were removed by centrifugation at 4,500g for 10-12 min at 4 °C. Lysed cells were centrifuged at 39,000g for 60 min at 4 °C to pellet total membranes. Total membranes were resuspended using a dounce homogenizer and extracted with 1% sarkosyl by stirring at 25 °C for 45 min. The outer membrane was pelleted by centrifugation at 39,000g for 60 min at 4 °C and then solubilized by resuspension using a dounce homogenizer in 
Expression and purification of the PapDG chaperone-adhesin complex.
Plasmids pDF1 (encoding PapD) and pTrcGII (encoding PapG) and the E. coli C600 strain were used for PapDG expression 21, 38 . Periplasm was prepared as described previously 16 . Periplasm was dialysed into 1× phosphate buffered saline supplemented with 250 mM NaCl (buffer C) and loaded onto a 
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In vitro reconstitution and purification of wild-type and mutant PapC-PapDG. Affinity-purified PapC (ε at 280 nm = 156,330 M −1 cm −1 , where ε is the protein extinction coefficient at an absorbance of 280 nm) and column-purified PapDG (ε at 280 nm = 99,615 M −1 cm −1 ) were mixed in a 1:1.2 molar ratio (2.2-6.3 µ M:2.6-7.5 µ M) in buffer B and allowed to form stable complexes by rotating gently at 4 °C for 1 h before size-exclusion chromatography (SEC). The mixture was concentrated using a 100 kDa molecular weight cut-off (MWCO) centrifugal device (Amicon), loaded onto a Superose 6 , 50 mM sodium citrate pH 5.0-6.0, 50 mM lithium sulfate, 50 mM sodium sulfate and 7-14% PEG 4000. Crystals of two distinct morphologies appeared in the same drops, and only plate-like crystals diffracted X-rays beyond 4 Å resolution. Crystals appeared within one week and grew to full size within two weeks. Plate-like crystals were flash-cooled in liquid nitrogen using the mother liquor supplemented with 5 mM CYMAL-5 and 30% (v/v) glycerol as a cryoprotectant. Diffraction data were collected at the Advanced Photon Source beamline 24-ID-E, and integrated and scaled using the HKL2000 package 39 . Because of strong anisotropy, the dataset was corrected using the UCLA-DOE Diffraction Anisotropy server 40 . After truncation, the resolution limits along the reciprocal cell directions a*, b* and c* were 3.7, 4.6 and 3.7 Å, respectively. An isotropic B-factor of − 47.12 Å 2 was applied to restore the magnitude of high-resolution reflections. The crystal belonged to space group C222 1 , with one PapC-PapDG complex per asymmetric unit.
Phasing was obtained by molecular replacement using Phaser with structures of the PapC translocation domain (Protein Data Bank (PDB) ID: 2VQI), PapD-PapG pilin domain (PDB ID: 2WMP), PapG lectin domain (PDB ID: 1J8S) and PapC CTD2 domain (PDB ID: 3L48) as search models 41 . Cycles of model building and refinement were carried out in Coot and REFMAC before building the remainder of the complex 42, 43 . For model building of the PapC NTD and CTD1, the PapC NTD and CTD1 models were first generated based on the full-length FimD structure (PDB ID: 3RFZ) using the SWISS-MODEL server 44 . The NTD model was fitted into the electron density using the rigid body fit in Coot and then manually adjusted. The PapC NTD tail (residues 1-30) and the linker between the PapC NTD and the translocation domain were manually built. At the CTD1 location, there was clear electron density corresponding to three β -strands, one of which connects to CTD2. Based on this observation, the CTD1 model was placed into the electron density and was then manually adjusted. The assignment of the sequence register for the PapC NTD and CTD1 was based on the model generated from SWISS-MODEL. The complete model was iteratively adjusted and refined. At the final refinement step, the TLS and 'jelly body' refinements were applied when running REFMAC. The final model, refined to R work /R free = 0.282/0.329 (the R value is the measure of the quality of the atomic model obtained from the crystallographic data), contains PapC residues 1-54, 67-248, 252-347, 355-430, 435-588, 592-633, 651-662, 672-687 and 714-808, PapD residues 1-215 and PapG residues 1-316. Residues without side-chain density were modelled as alanine. The percentages of residues in favoured, allowed and disallowed regions of the Ramachandran plot were 92, 8 and 0%, respectively.
Calculation of domain movements using DynDom. Domain movements between the pre-activation and post-activation usher states were calculated using the DynDom Protein Domain Motion Analysis web server 45 . DynDom requires the use of two different conformations of the same protein or protein complex. To create a post-activation PapC-PapDG usher model, the individual translocation domain, NTD and CTD2 domains were superimposed to the corresponding domains in the FimD-FimCH structure (PDB ID: 3RFZ) and each resulting superimposed domain was exported as a molecule. Merging the coordinates of the translocation domain and NTD or translocation domain and CTD2 created models of the post-activation TD-NTD and TD-CTD2 structures, where the translocation domain was used as the static domain and the NTD or CTD2 were considered dynamic domains. To create an equivalent model in the pre-activation usher state, TD-NTD or TD-CTD2 were exported as molecules from our solved structure. Pre-activation TD-NTD or TD-CTD2 and post-activation TD-NTD or TD-CTD2 molecules were input as conformer 1 and conformer 2, respectively. The resulting output reported the translation and rotation for the dynamic domain in question, which are described in the figure legends.
Functional analysis of PapC mutants. All PapC mutants were derived from plasmid pDG2 using site-directed mutagenesis 37 . We created the following mutations: (1) substitution of residues 12-21 to alanine (12-21A); (2) substitution of residues 16-20 to alanine (16-20A); (3) introduction of a proline residue at position 17 (D17P) and position 19 (T19P) to specifically disrupt the beginning and middle of the NTD N-terminal α -helix; and (4) substitution of alanine for a conserved phenylalanine (F745A) in CTD2. All constructs generated using sitedirected mutagenesis methods were sequenced to verify that the correct mutations had been made. The haemagglutination titre assay was performed on C600 cells harbouring pEV33 (ref. 46 ), a tetracycline-resistant, tryptic soy agar-inducible plasmid containing the entire pap operon with PapC inactivated by a XhoI linker, and each papC mutant plasmid. The cells were induced by overnight growth on selective tryptic soy agar media supplemented with 100 µ g ml −1 ampicillin, 15 µ g ml −1 tetracycline and 0.005% l-arabinose. Haemagglutination assay titres were performed as previously described 47 . The haemagglutination assay end point was defined as the last dilution well before erythrocyte buttons formed. Titres are represented as the reciprocal of the end-point dilution. The statistical significance of differences between wild-type and mutant PapC in the experiments was determined by an unpaired two-tailed Mann-Whitney U-test. Statistical analyses were performed using GraphPad Prism 7. 
nature research | reporting summary
Statistical parameters
When statistical analyses are reported, confirm that the following items are present in the relevant location (e.g. figure legend, table legend, main text, or Methods section).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement An indication of whether measurements were taken from distinct samples or whether the same sample was measured repeatedly
The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection
Diffraction data were collected at the Advanced Photon Source beamline 24-ID-E. Specifically, data were collected at the NE-CAT beamlines (GM103403) using a Pilatus detector (RR029205) and an Eiger detector (OD021527).
Data analysis
GraphPad Prism 7 was used to analyze assays and visualize data shown in Figure 3d and Extended Data Figure 5 . BioRad Image Lab software was used to visualize images shown in Figure 1c and Figure 4e . BioRad Image Lab software was used to quantify data shown in Extended Data Figure 4f . X-ray diffraction data was processed and analyzed using the following programs/servers: HKL2000, UCLA-DOE Diffraction Anisotropy Server, Phaser, Coot, REFMAC, SWISS-MODEL server, and DynDom Protein Domain Motion Analysis web server (see Methods).
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